Pharmacoflash 24 : Pharmacogenetics

15:15 • 220 • Exploring the contribution of CYP pharmacogenetics to methadone enantiomeric distribution in postmortem setting > Y. Yassir Tbibi 15:21 • 683 • Prediction of Tacrolimus-Posaconazole Interactions in Renal Transplant Patients with Different CYP3A5 Genotypes Based on Physiological Pharmacokinetic Models > H. Hu Nan 15:27 • 634 • Reevaluation of the DPYD*6 Variant: Significant Association with Elevated Uracil as a Marker of Impaired DPD Function In Vivo > X. Xavier Fonrose 15:33 • 544 • Direct comparison of DPYD genotyping versus DPD phenotyping for predicting life-threatening toxicities to fluoropyrimidines. > J. Jean Christophe Boyer 15:39 • 244 • Genetic variants associated with anthracycline-induced cardiotoxicity in paediatric oncology: a case-control study > J. Julia Netylko 15:45 • 243 • Genotype informed Bayesian dosing of tacrolimus in paediatric solid organ transplant patients > J. Julia Netylko 15:51 • 611 • Operational Feasibility and Molecular Yield of Broad Genomic Sequencing in Early-Phase Oncology Trials: Addressing the "Precision Gap" > I. Ivana Spasojevic